HMGB1 and melanoma: On RAGE independent pathways, HMGB1 interacts with erythropoietin-producing human hepatocellular B4 (EPHB4), NF-κB, TLR4 and melanoma inhibitory activity (MIA) protein to induce its tumorigenic effects and affect autophagy.